Synovial Sarcoma

A scientist wearing blue gloves holds a flask with blue liquid in a laboratory, surrounded by various glassware and a microscope in the background.
Research

Revolutionary Insights Unveiled in Latest Synovial Sarcoma Research

December 4, 2025 Comments Off on Revolutionary Insights Unveiled in Latest Synovial Sarcoma Research

A landmark study just published in Nature Communications finally pinpointed the exact “cell of origin” for synovial sarcoma — a rare, primitive fibroblast that still carries embryonic markers (Hic1⁺ Pdgfra⁺ Lgr5⁺). Breaking 2025 Research: Read the entire article here. Learn more about our world-renowned registry efforts here.

A smiling man in a gray suit, light blue shirt, and red tie poses for a professional headshot against a brown, softly blurred background.
CHOP, Dr. Theodore Laetsch

Dr. Theodore W. Laetsch, Synovial Sarcoma Foundation Board Member, Receives $1 Million Grant to Advance Rare Tumor Studies

September 29, 2025 Comments Off on Dr. Theodore W. Laetsch, Synovial Sarcoma Foundation Board Member, Receives $1 Million Grant to Advance Rare Tumor Studies

The Synovial Sarcoma Foundation is pleased to highlight a significant milestone at the Children’s Hospital of Philadelphia (CHOP), where pediatric oncologist and Synovial Sarcoma Foundation Board Member, Dr. Theodore W. Laetsch, has been awarded a prestigious $1 million multi-year grant from the National Cancer Institute (NCI). This funding aims to accelerate research and treatment development […]

A stethoscope and a blue pen resting on top of a medical chart with patient information and handwritten notes.
Latest News, Research

Innovative Approach Shows Promise Against Synovial Sarcoma Using Protein-Blocking Drugs

September 11, 2025 Comments Off on Innovative Approach Shows Promise Against Synovial Sarcoma Using Protein-Blocking Drugs

The Synovial Sarcoma Foundation is dedicated to supporting cutting-edge research that advances treatment options for this rare and aggressive cancer. Recent findings published in The EMBO Journal highlight a promising new strategy: using drug blockers to target a problematic protein involved in synovial sarcoma’s genetics. Synovial sarcoma primarily develops in soft tissues such as muscles […]